Identification of ESM-1 as a new endothelial biomarker in the pathogenesis of rheumatoid arthritis

References

• Béchard D, Gentina T, Delehedde M, et al. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem. 2001;276:48341–48349.
   PubMed Web of Science ®Google Scholar
• Lassalle P, Molet S, Janin A, et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996;271:20458–20464.
   PubMed Web of Science ®Google Scholar
• Bechard D, Meignin V, Scherpereel A, et al. Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res. 2000;37:417–425.
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Charakida M, Stefanadis C. Endothelial function and inflammation in coronary artery disease. Heart. 2006;92:441–444.
   PubMed Web of Science ®Google Scholar
• Kharbanda RK, Walton B, Allen M, et al. Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin. Circulation. 2002;105:2600–2604.
   PubMed Web of Science ®Google Scholar
• Steyers CM III, Miller FJ Jr. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15:11324–11349.
   PubMed Web of Science ®Google Scholar
• Spinelli FR, Di Franco M, Metere A, et al. Decrease of asymmetric dimethyl arginine after anti-TNF therapy in patients with rheumatoid arthritis. Drug Dev Res. 2014;75:S67–S69.
   PubMed Web of Science ®Google Scholar
• Mosevoll KA, Lindås R, Wendelbo O, et al. Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis. SpringerPlus [Internet]. 2014;3:571. Available from: http://www.springerplus.com/content/3/1/571
   PubMed Web of Science ®Google Scholar
• Adekola H, Romero R, Chaemsaithong P, et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med. 2014;28:1–12.
   PubMed Web of Science ®Google Scholar
• Sarrazin S, Adam E, Lyon M, et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta. 2006;1765:25–37.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–1588.
   PubMed Web of Science ®Google Scholar
• Cohen JD, Dougados M, Goupille P, et al. Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis. J Rheumatol. 2006;33:1936–1941.
   PubMed Web of Science ®Google Scholar
• Klarenbeek NB, Koevoets R, van der Heijde DM, et al. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis. Ann Rheum Dis. 2011;70:1815–1821.
   PubMed Web of Science ®Google Scholar
• Sattar N, McCarey DW, Capell H, et al. Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003;108:2957–2963.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Inflammation and endothelial dysfunction in rheumatoid arthritis. Clin Exp Rheumatol. 2006;24:115–117.
   PubMed Web of Science ®Google Scholar
• Soltész P, Dér H, Kerekes G, et al. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol. 2009;28:655–662.
   PubMed Web of Science ®Google Scholar
• Vaudo G, Marchesi S, Gerli R, et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis. 2004;63:31–35.
   PubMed Web of Science ®Google Scholar
• Klimek E, Skalska A, Kwaśny-Krochin B, et al. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. Mediat Inflamm [Internet]. 2014;2014:681635. Available from: http://dx.doi.org/10.1155/2014/681635
   PubMed Web of Science ®Google Scholar
• Hjeltnes G, Hollan I, Førre Ø, et al. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients. Scand J Rheumatol. 2011;40:422–427.
   PubMed Web of Science ®Google Scholar
• Korkosz M, Gąsowski J, Surdacki A, et al. Disparate effects of anti-TNF-α therapies on measures of disease activity and mediators of endothelial damage in ankylosing spondylitis. Pharmacol Rep. 2013;65:891–897.
   PubMed Web of Science ®Google Scholar
• Sen A, Most P, Peppel K. Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunction. FEBS Lett. 2014;588:906–914.
   PubMed Web of Science ®Google Scholar
• Moelants EA, Mortier A, Van Damme J, et al. Regulation of TNF-α with a focus on rheumatoid arthritis. Immunol Cell Biol. 2013;91:393–401.
   PubMed Web of Science ®Google Scholar
• Spinelli FR, Metere A, Barbati C, et al. Effect of therapeutic inhibition of TNF on circulating endothelial progenitor cells in patients with rheumatoid arthritis. Mediat Inflamm [Internet]. 2013;2013:537539. Available from: http://dx.doi.org/10.1155/2013/537539
   PubMed Web of Science ®Google Scholar
• Balta I, Balta S, Demirkol S, et al. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol. 2013;169:1066–1070.
   PubMed Web of Science ®Google Scholar
• Balta I, Balta S, Koryurek OM, et al. Serum endocan levels as a marker of disease activity in patients with Behçet disease. J Am Acad Dermatol. 2014;70:291–296.
   PubMed Web of Science ®Google Scholar